The present invention relates to the discovery that of a panel of serum or plasma markers may be used to diagnose Idiopathic Pulmonary Fibrosis (“IPF”) and distinguish this condition from other lung ailments. It further relates to the identification of markers associated with IPF disease progression
Idiopathic pulmonary fibrosis (IPF) is a rare and devastating lung disease of unknown aetiology. Iti...
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia an...
Interstitial lung diseases (ILD) are a heterogeneous group of illnesses of known and unknown aetiolo...
The present invention relates to the discovery that of a panel of serum or plasma markers may be use...
Disclosed are methods are kits for evaluating predicting whether an individual IPF has slowly or rap...
Accurate assessment of idiopathic pulmonary fibrosis (IPF) disease severity is integral to the care ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fibrotic interstitial lung diseas...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung fibrosis with an unk...
peer reviewedPulmonary fibrosis is a pathological entity still too little understood today, burdened...
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which circulatory b...
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease ...
Diagnosis of idiopathic pulmonary fibrosis (IPF) is challenging, and the cooperation between differe...
In this thesis the search for a prognostic biomarker in idiopathic pulmonary fibrosis (IPF) is descr...
With the recent development of two effective treatments for patients with idiopathic pulmonary fibro...
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias, an...
Idiopathic pulmonary fibrosis (IPF) is a rare and devastating lung disease of unknown aetiology. Iti...
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia an...
Interstitial lung diseases (ILD) are a heterogeneous group of illnesses of known and unknown aetiolo...
The present invention relates to the discovery that of a panel of serum or plasma markers may be use...
Disclosed are methods are kits for evaluating predicting whether an individual IPF has slowly or rap...
Accurate assessment of idiopathic pulmonary fibrosis (IPF) disease severity is integral to the care ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fibrotic interstitial lung diseas...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung fibrosis with an unk...
peer reviewedPulmonary fibrosis is a pathological entity still too little understood today, burdened...
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which circulatory b...
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease ...
Diagnosis of idiopathic pulmonary fibrosis (IPF) is challenging, and the cooperation between differe...
In this thesis the search for a prognostic biomarker in idiopathic pulmonary fibrosis (IPF) is descr...
With the recent development of two effective treatments for patients with idiopathic pulmonary fibro...
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias, an...
Idiopathic pulmonary fibrosis (IPF) is a rare and devastating lung disease of unknown aetiology. Iti...
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia an...
Interstitial lung diseases (ILD) are a heterogeneous group of illnesses of known and unknown aetiolo...